| | Main Menu | Back to Activity by Object - FY 2026 | |
Activity for Object 3986 - Unexpended Cash Balance Forward --Operating Transfers In
Fund 5136 - GR Account - Cancer Prevention and Research
Fiscal Year 2026 activity September 1, 2025 - April 30, 2026
Prior fiscal years September 1 - August 31
| Fiscal Year | Revenue | Expenditures | Net Activity | |
|---|---|---|---|---|
 |
2026 | 903,021.95 | 0.00 | 903,021.95 |
|
2025 | 872,521.95 | 0.00 | 872,521.95 |
|
2024 | 1,636,419.45 | 0.00 | 1,636,419.45 |
|
2023 | 584,764.45 | 0.00 | 584,764.45 |
|
2022 | 985,128.90 | 0.00 | 985,128.90 |
|
2021 | 47,600.00 | 0.00 | 47,600.00 |
|
2020 | 492,564.45 | 0.00 | 492,564.45 |
|
2019 | 985,164.48 | 0.00 | 985,164.48 |
|
2018 | 122.08 | 0.00 | 122.08 |
|
2017 | 1,563,186.19 | 0.00 | 1,563,186.19 |
|
2016 | 1,288,961.19 | 0.00 | 1,288,961.19 |
|
2015 | 238,847.00 | 0.00 | 238,847.00 |
|
2014 | 15,229.83 | 0.00 | 15,229.83 |
|
2011 | 16,873.79 | 0.00 | 16,873.79 |